BSE Live
Dec 30, 16:01Prev. Close
1433.75
Open Price
1434.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 30, 15:57Prev. Close
1434.60
Open Price
1440.00
Bid Price (Qty.)
1386.20 (1952)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Ipca Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 20.29 | 37.83 | 26.27 | 22.23 | 20.36 | |
| Diluted EPS (Rs.) | 20.29 | 37.83 | 26.27 | 22.22 | 20.35 | |
| Cash EPS (Rs.) | 34.33 | 45.82 | 32.92 | 27.45 | 24.73 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 176.97 | 157.02 | 124.39 | 100.29 | 83.84 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 176.97 | 157.02 | 124.39 | 100.29 | 83.84 | |
| Dividend / Share(Rs.) | 1.00 | 5.00 | 4.00 | 3.20 | 3.20 | |
| Revenue from Operations/Share (Rs.) | 244.46 | 256.32 | 220.16 | 185.09 | 149.65 | |
| PBDIT/Share (Rs.) | 44.08 | 59.79 | 45.69 | 37.63 | 34.02 | |
| PBIT/Share (Rs.) | 30.04 | 51.80 | 39.04 | 32.44 | 29.61 | |
| PBT/Share (Rs.) | 28.35 | 49.85 | 36.56 | 29.32 | 26.55 | |
| Net Profit/Share (Rs.) | 20.29 | 37.83 | 26.26 | 22.26 | 20.32 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 18.03 | 23.32 | 20.75 | 20.33 | 22.73 | |
| PBIT Margin (%) | 12.28 | 20.20 | 17.73 | 17.52 | 19.78 | |
| PBT Margin (%) | 11.59 | 19.44 | 16.60 | 15.83 | 17.74 | |
| Net Profit Margin (%) | 8.30 | 14.75 | 11.92 | 12.02 | 13.57 | |
| Return on Networth / Equity (%) | 11.46 | 24.09 | 21.10 | 22.19 | 24.23 | |
| Return on Capital Employed (%) | 8.74 | 19.59 | 15.93 | 16.53 | 19.11 | |
| Return on Assets (%) | 6.69 | 14.83 | 12.23 | 12.02 | 13.34 | |
| Total Debt/Equity (X) | 0.37 | 0.22 | 0.33 | 0.42 | 0.43 | |
| Asset Turnover Ratio (%) | 80.68 | 100.55 | 102.57 | 99.97 | 98.32 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.78 | 2.03 | 2.20 | 1.88 | 1.79 | |
| Quick Ratio (X) | 0.76 | 0.95 | 1.03 | 0.84 | 0.99 | |
| Inventory Turnover Ratio (X) | 3.36 | 3.86 | 3.79 | 3.51 | 4.07 | |
| Dividend Payout Ratio (NP) (%) | 4.92 | 13.21 | 15.22 | 14.38 | 15.74 | |
| Dividend Payout Ratio (CP) (%) | 2.91 | 10.91 | 12.15 | 11.66 | 12.93 | |
| Earnings Retention Ratio (%) | 95.08 | 86.79 | 84.78 | 85.62 | 84.26 | |
| Cash Earnings Retention Ratio (%) | 97.09 | 89.09 | 87.85 | 88.34 | 87.07 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 8,767.69 | 11,021.97 | 7,114.38 | 4,738.27 | 4,240.64 | |
| EV/Net Operating Revenue (X) | 2.84 | 3.41 | 2.56 | 2.03 | 2.25 | |
| EV/EBITDA (X) | 15.76 | 14.61 | 12.34 | 10.00 | 9.92 | |
| MarketCap/Net Operating Revenue (X) | 2.61 | 3.30 | 2.39 | 1.81 | 2.02 | |
| Retention Ratios (%) | 95.07 | 86.78 | 84.77 | 85.61 | 84.25 | |
| Price/BV (X) | 3.61 | 5.38 | 4.23 | 3.34 | 3.60 | |
| Price/Net Operating Revenue | 2.61 | 3.30 | 2.39 | 1.81 | 2.02 | |
| Earnings Yield | 0.03 | 0.04 | 0.05 | 0.07 | 0.07 |
05.12.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
17.11.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher